Skip to content

Skyrizi 19558595

by Abbvie Inc.

Skyrizi 19558595 is a Class II device made by Abbvie Inc., listed in FDA GUDID since 7 Jul 2022 (UDI-DI 48054083023234), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number48054083023234 UDI-DI Date7 Jul 2022ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Skyrizi
Generic name
Subcutaneous self-injection aid
Model / reference
19558595
Primary DI / UDI-DI
48054083023234
FDA product code
QLF
GMDN term
Subcutaneous self-injection aid
Device class
Class II
Regulation number
880.5860
GUDID distribution status
In Commercial Distribution
Sterilisation method
Ethylene Oxide
MRI safety
MR Unsafe
Size
Width — 41 Millimeter
Length — 85 Millimeter
Height — 22.5 Millimeter

Related devices

Category: Subcutaneous self-injection aid

Other devices from Abbvie Inc.

See all devices from Abbvie Inc. →

Properties

  • Supplied sterile
  • Sterilise before use
  • Single use
  • Prescription use
  • Lot / batch number
  • Serial number
  • Manufacturing date
Other properties (8, all answered No)